Macrophage migration inhibitory factor (MIF) functions as a proinflammatory cytokine when secreted from the cell, but it also exhibits antioxidant properties by virtue of its intrinsic oxidoreductase activity. Since increased production of ROS is implicated in the development of left ventricular hypertrophy, we hypothesized that the redox activity of MIF protects the myocardium when exposed to hemodynamic stress. In a mouse model of myocardial hypertrophy induced by transverse aortic coarctation (TAC) for 10 days, we showed that growth of the MIF-deficient heart was significantly greater by 32% compared with wild-type (WT) TAC hearts and that fibrosis was increased by fourfold (2.62 Ϯ 0.2% vs. 0.6 Ϯ 0.1%). Circulating MIF was increased in TAC animals, and expression of MIF receptor, CD74, was increased in the hypertrophic myocardium. Gene expression analysis showed a 10-fold increase (P Ͻ 0.01) in ROS-generating mitochondrial NADPH oxidase and 2-to 3-fold reductions (P Ͻ 0.01) in mitochondrial SOD2 and mitochondrial aconitase activities, indicating enhanced oxidative injury in the hypertrophied MIF-deficient ventricle. Hypertrophic signaling pathways showed that phosphorylation of cytosolic glycogen synthase kinase-3␣ was greater (P Ͻ 0.05) at baseline in MIF-deficient hearts than in WT hearts and remained elevated after 10-day TAC. In the hemodynamically stressed MIFdeficient heart, nuclear p21 CIP1 increased sevenfold (P Ͻ 0.01), and the cytosolic increase of phospho-p21 CIP1 was significantly greater than in WT TAC hearts. We conclude that MIF antagonizes myocardial hypertrophy and fibrosis in response to hemodynamic stress by maintaining a redox homeostatic phenotype and attenuating stressinduced activation of hypertrophic signaling pathways.
HYPERTROPHY OF THE HUMAN HEART, comprising pathological changes in myofibrillar contractile function, chamber geometry, fibrosis, vascularization, and metabolic processes, is a significant independent risk factor for increased mortality (24, 53) . Maladaptive or pathologic left ventricular (LV) hypertrophy can occur in response to many diverse stimuli, including systemic arterial hypertension, aortic stenosis, or remodeling of the viable myocardium after coronary artery occlusion and infarction (11) . Extensive research efforts over the past decades have identified key molecular mechanisms contributing to the pathological processes in cardiac hypertrophy, which has lead to the development of successful treatment options for patients living with heart failure, including the use ␤-adrenergic receptor blockers, diuretics, angiotensin-converting enzyme inhibitors, and angiotensin type 1 receptor blockers (32) . Despite the improved outcomes of these treatments of heart failure patients, the prevalence of this disease is on the rise due to the increased incidence of diabetes and obesity as well as an aging population. These changing demographics will likely require multiple treatment options at all stages of this disease.
To this end, we investigated the role of macrophage migration inhibitory factor (MIF), an evolutionarily conserved ubiquitously expressed protein known to function as a regulator of immune responses in acute and chronic inflammatory diseases (15) and, as shown recently, to maintain redox homeostasis in the postischemic myocardium (22, 29) . MIF has two distinct enzymatic activities: tautomerase/isomerase activity, which resides at the amino terminal of the protein and is necessary for its proinflammatory function, and oxidoreductase activity, which is within a thiol protein motif (Cys 57 -X-X-Cys 60 ) and acts as a redox catalyst similar to peroxiredoxins (21, 51) . Recently, Luedike et al. (29) have shown that increased Snitrosylation of Cys 81 of MIF occurs in the postischemiareperfused heart, which promoted the oxidoreductase activity of MIF, thus reducing cardiomyocyte apoptosis and infarct size. Furthermore, Cys 81 nitrosylation was shown to reduce MIF interactions with Jun activation domain-binding protein-1 (Jab1)/CSN5, presumably leading to increased availability of MIF during reperfusion or to altered function of the CSN5/ COP9 signalosome complex (47) . Our previously published study (22) supported a cardioprotective role of MIF after ischemia-reperfusion by reducing oxidative stress as measured by higher GSH-to-GSSG ratios, reduced protein oxidation, and mitochondrial damage, resulting in a smaller infarct size and improved contractile function. In addition to its intrinsic redox activity, secreted MIF has CD74/CD44 membrane receptorinitiated activities in cardiomyocytes, which stimulate prosurvival signaling pathways, including AMP kinase, Akt, and ERK1/2 (36, 45) . Thus, MIF shares many characteristics of other redox proteins, including thioredoxin, which possess cytokine-like activity, promote cell growth, and have intracellular redox capacity (2, 39, 57) .
The role of MIF in promoting cell cycle progression and proliferation is supported by its regulation of SCF ubiquitin ligases and degradation of cell cycle regulators and by the observation that knockdown of MIF inhibits cell proliferation and mediates cell cycle arrest in the G 0 /G 1 phase (26, 40) . MIF overexpression has been observed in various human cancers (37) . Conversely, MIF has been shown to inhibit cell growth by antagonizing Jab1/CSN5-modulated functions, including activator protein-1 transcriptional activity, JNK activation, and cell cycle inhibitor p27
Kip1 expression (14, 18, 20, 54) . MIF bind-ing to Jab1/CSN5 is thought to inhibit CSN5-metalloprotease removal of Nedd8 from cullin, a posttranslational modification that promotes cullin's ubiquitin E3 ligase activity and, thus, regulates proteasome-dependent proteolysis of unique proteins, possibly p53 and p27 Kip1 (27) . Some studies (13, 17) have shown that inactivation of p27 Kip1 and p21 CIP1 is crucial for stress-induced cardiac hypertrophic growth, whereas others (10, 46) have shown that these proteins serve other functions, such as regulating actin dynamics, promoting cell migration, and inducing cardiac fibroblast differentiation to myofibroblasts. We therefore examined the effect of a hypertrophic stimulus on these proteins to determine whether they played a role in promoting growth in the MIF-deficient heart.
To test our hypothesis that MIF functions to reduce myocyte stress and antagonize hemodynamic-mediated growth, we used a model of pressure overload-induced cardiac hypertrophy in MIF-deficient mice. The results of the present study support a primary role of MIF in reducing cellular stress, such that a deficiency of MIF augments cardiomyocyte hypertrophy, increases fibrosis, and induces an oxidative stress phenotype in response to hemodynamic overload.
MATERIALS AND METHODS
Animal protocols. All animals used in the experiments were treated in accordance with National Institutes of Health (NIH) guidelines for the use and care of laboratory animals (NIH Pub. No. 85-23), and all study protocols were approved by the Animal Care and Use Committee of The Feinstein Institute. MIF-deficient [mif Ϫ/Ϫ ; knockout (KO)] mice were originally developed as described by Bozza et al. (4) and, for this study, were bred and maintained in The Feinstein Institute. Wild-type (WT) C57BL/6 male mice were purchased from Taconic Farms (Albany, NY). Mean body weights before surgery of 9-wk-old male WT and MIF KO mice were 22.6 Ϯ 0.3 and 21.2 Ϯ 0.2 g, respectively. Cardiac hypertrophy was produced by coarctation of the transverse thoracic aorta [transverse aortic coarctation (TAC)], as previously published (1) . Briefly, mice were intubated and anesthetized using isofluorane; respiration was controlled by mechanical ventilation (Harvard Apparatus, Boston, MA). The left thorax was opened at the second intercostal space to expose the aortic arch, and the transverse aorta between the left common carotid artery and innominate artery was constricted using a suture tied around a 27-gauge needle. Sham surgery (sham animals) was similarly performed without aortic constriction. Mice were maintained for 10 or 28 days. Mortality was Ͻ1% over this time period and was similar for both groups. Body weight gains after 10-and 28-day TAC were not statistically different between WT and MIF KO mice (0.62 Ϯ 0.11 and 0.52 Ϯ 0.09 g after 10-day TAC; 1.48 Ϯ 0.13 and 1.41 Ϯ 0.14 g after 28-day TAC, respectively). Thus, heart weight-to-body weight ratios reflected cardiac hypertrophy and not changes in body weight. Arterial pressure gradients across the constriction were measured using pressure catheters (1.4-Fr, Millar Instruments, Houston, TX) inserted into the left and right carotid arteries, and data were collected and analyzed using a PowerLab 8/30 acquisition system (AD Instruments, Colorado Springs, CO). Pressure gradients were similar in TAC groups, with mean pressures of 26 Ϯ 3 and 22 Ϯ 8 mmHg for WT and MIF KO animals, respectively. Mean Ϯ SE right and left carotid artery pressures were 89.5 Ϯ 7.8 and 65.5 Ϯ 6.9 mmHg for WT mice and 88.7 Ϯ 4.9 and 70.8 Ϯ 4.8 mmHg for MIF KO mice. Mean heart rates for WT and KO mice were 527 Ϯ 19 and 563 Ϯ 25 beats/min, respectively. There were no statistical differences in these measurements between groups. Data obtained from 21 WT sham, 27 WT 10-day TAC, 20 MIF KO sham, and 26 MIF KO 10-day TAC mice were used for the various analyses reported in this study.
Analysis of inflammatory cytokines. Arterial blood samples were collected into heparinized tubes at the end of the experimental period before removal of the heart. Plasma was processed and stored at Ϫ80°C until analyzed for cytokines/chemokines using the MSD mouse proinflammatory7-plex ultra-sensitive 96-well assay system (Meso Scale Diagnostics, Gaithersburg, MD). Seven cytokines [IL-1␤, IL-12 p70, IFN-␥, IL-6, KC/growth-related protein (GRO), IL-10, and TNF-␣] were simultaneously measured in duplicate samples of 25-l plasma and quantified using standard curves of each cytokine.
Tissue homogenization and immunoblot analysis. Hearts were excised and weighed, and the LV, including the septum, was isolated, immediately frozen in liquid nitrogen, and stored at Ϫ80°C. Frozen tissue was homogenized, and cytosolic, nuclear, and mitochondrial fractions were prepared as we have previously described (22 Signals from horseradish peroxidase-conjugated secondary antibodies (polyclonal or monoclonal) were developed using chemiluminescence reagent (Perkin-Elmer, Waltham, MA) and detected by exposure to X-ray film. Protein band intensities were quantified by laser scanning densitometry (GS-800 Densitometer, Bio-Rad, Hercules, CA). Data are expressed as arbitrary densitometric units.
Tissue RNA extraction and quantitative RT-PCR. Total RNA was isolated from 30 to 40 mg of LV tissue using commercially available kits (Qiagen, Valencia, CA), and purity and integrity of the RNA were assessed using a bioanalyzer (Agilent Technologies, Wilmington, DE). RNA (0.3 g/sample) was used for oxidative stress/antioxidant defense pathway-focused gene expression profiling as recommended by the manufacturer (84 Gene RT Histological analysis. Hearts from 10-day TAC and sham animals were formalin fixed and paraffin embedded. Four longitudinal sections (5 m) cut from the midheart area were prepared on glass slides, deparaffinized, and stained for collagen using Masson's trichrome staining procedures (American MasterTech, Lodi, CA). LV sections were visualized microscopically (Zeiss Axiovert 200M), images were captured, and areas of fibrosis were quantified using ImageJ software (NIH) and expressed as a fraction of the total LV (free wall plus septum) area. To measure the infiltration of inflammatory granulocytes into the heart after 10-day TAC, paraffin-embedded tissue slides were deparaffinized and stained for esterase activity using the substrate naphthol AS-D chloroacetate, essentially as described by the manufacturer (Sigma-Aldrich, St. Louis, MO).
Measurement of oxidative enzyme activities. Activities of SOD and aconitase in mitochondrial and cytoplasmic fractions and cytosolic glutathione peroxidase (GPX) were measured in extracted LV tissue using commercially available assay kits following the manufacturer's recommendations (Cayman Chemical, Ann Arbor, MI).
Culture of neonatal rat ventricular myocytes and adenoviral transduction. Ventricular myocytes were isolated from hearts of 2-day-old rats by collagenase digestion as we have previously described (19) . Myocytes were plated at ϳ1.5 ϫ 10 4 cells/cm 2 on collagen-coated 60-mm dishes, cultured for the first 20 h in DMEM-F-12 medium containing 10% FBS, L-glutamine, cytosine ␤-D-arabino-furanoside (10 M), and antibiotics, and then transduced with adenovirus (75 multiplicity of infection) expressing WT MIF (Ad-MIF) or Ad-LacZ, as we have previously described (22) . To study the oxidoreductase function of MIF, this enzyme activity was rendered inactive by mutating Cys 60 to Ser 60 at the thiol protein oxidoreductase site using site-directed mutagenesis as recommended by the manufacturer (Stratagene, La Jolla, CA). Recombinant adenovirus was constructed, which expressed redox inactive MIF and human recombinant green fluorescent protein (GFP) from a dicistronic gene (Ad-C60S). Forty-eight hours after viral transduction, Ͼ90% of the cardiomyocytes expressed exogenous protein, as determined by GFP fluorescence imaging. Neonatal rat ventricular myocytes (NRVMs) were then exposed to 16 h of hypoxia (Ͻ1% O 2) or to 16 h of hypoxia followed by 1 h of reoxygenation before being harvested. In some experiments, transduced NRVMs were treated with the reducing agent N-mercaptopropionylglycine (2-MPG; 400 M) during the period of hypoxia/reoxygenation. Western blot analysis of MIF expression (anti-MIF antibodies, catalog no. ab7207, Abcam) was used to verify Ad-MIF or Ad-C60S overexpression.
Reagents used in cell culture were of the highest quality available (Calbiochem, San Diego, CA; Life Technologies/GIBCO, Grand Island, NY).
Measurement of apoptosis and oxidative stress in cultured cardiomyocytes. Cell fractionation of cytoplasmic and nuclear proteins for immunoblot analysis was done as previously described (19) . Cleaved caspase 3 (Cell Signaling Technology) was quantified by immunoblot analysis and normalized to GAPDH as a measure of cell apoptosis. Additionally, apoptosis was quantified using a commercially available ELISA kit (Roche, Nutley, NJ) that detected cytoplasmic mono-and oligonucleosomes using anti-histone antibodies. Concentrations of GSH and GSSG were determined by the established glutathione reductase/ 5,5=-dithiobis(2-nitrobenzoic acid) recycling procedure using a commercially available kit (Cayman Chemical), as we have previously described (22) .
Statistical analysis. Data are presented as means Ϯ SE. Sample numbers per group are indicated in the RESULTS and figures. Statistical analysis was performed using a paired Student's t-test or one-way ANOVA followed by Holm-Sidak post hoc analysis. P values of Ͻ0.05 were considered statistically significant. Statistical analysis used SigmaStat 3.1 (Systat Software, Richmond, CA).
RESULTS
Augmented hypertrophic responses to pressure overload in MIF KO hearts. To determine whether endogenous MIF plays a role in regulating cardiomyocyte growth, MIF KO and WT mice were subjected to TAC for 10 or 28 days. Hearts that were deficient in MIF were 32% larger (P Ͻ 0.01) than WT hearts after 10 days of pressure overload, and this difference persisted to 28 days (Fig. 1A) . Furthermore, after 10-day TAC, LV fibrosis as measured by collagen staining was 4.4-fold higher (P Ͻ 0.001) in the MIF-deficient ventricle compared with the WT ventricle (Fig. 1B) . To determine whether there was inflammation in the hypertrophied hearts, we stained tissue sections for esterase activity, which would indicate infiltration of cells of the granulocytic lineage. We failed to observe any positive cells after 10-day TAC in either WT or MIF KO hearts (data not shown).
MIF has been shown to be released from the heart and other tissues in response to oxidative stress (36, 49) ; therefore, we measured its content in LV tissue and in the blood of TAC animals. MIF was detected in the plasma of WT 10-day TAC mice and remained elevated after 28-day TAC (P Ͻ 0.01), with no significant reduction in tissue MIF levels (Fig. 1C) . Secreted MIF can function in an autocrine/paracrine manner by binding to CD74 cell surface receptors, which we found to be significantly elevated in hypertrophied ventricles of both WT and MIF KO mice after 10-day TAC (Fig. 1D ). Previously published studies have shown that extracellular recombinant MIF phosphorylates AMP kinase (36) and thus confers protection of the postischemic myocardium (45) . In the present study, pressure overload-induced hypertrophy had no effect on AMP kinase activation in MIF KO or WT hearts (data not shown).
Inflammatory response in pressure overload-induced myocardial hypertrophy. To determine whether the complete absence of MIF changed the inflammatory response to pressure overload, we measured plasma concentrations of seven cytokines/chemokines, including IL-1␤, IL-12 p70, IFN-␥, IL-6, KC/GRO, IL-10, and TNF-␣. We found no significant responses in any cytokine in either WT or MIF KO mice after 10 or 28 days of pressure overload compared with sham control mice. However, there was a trend for IL-1␤ to increase in both WT and MIF KO mice after 10-day TAC (0.39 Ϯ 0.01, 0.96 Ϯ 0.10, 0.34 Ϯ 0.03, and 0.65 Ϯ 0.28 pg/ml in WT sham, WT TAC, MIF KO sham, and MIF KO TAC mice, respectively). Additionally, the anti-inflammatory cytokine IL-10 showed a nonsignificant decrease in 10-day TAC animals (154.0 Ϯ 4.1, 79.4 Ϯ 67.6, 180.0 Ϯ 27.0, and 137.7 Ϯ 20.3 pg/ml in WT sham, WT TAC, MIF KO sham, and MIF KO TAC mice, respectively).
Differential induction of oxidative stress genes in the hypertrophied MIF-deficient myocardium. We (22) have previously shown that oxidative stress is greater in the MIF-deficient postischemic myocardium. Therefore, we investigated the response of stress/antioxidant genes in hypertrophied hearts after 10-day TAC to determine whether MIF deficiency leads to an enhanced response to cellular stress. Of the 84 oxidative stress genes measured in the PCR array, the expression of 20 genes was significantly altered in response to pressure overload in either MIF KO or WT hearts compared with WT sham mice. In general, genes encoding proteins with antioxidant function were reduced, whereas those that promoted oxidative stress were increased. The fold regulation and P values of these genes are shown in Table 1 . Expression of two stress genes was significantly greater at baseline (sham) in MIF KO compared with WT mice, namely, thioredoxin reductase and xin actinbinding repeat containing 1 (Xirp1), an F-actin-binding protein recently shown to be upregulated in injured muscle, possibly involved in cellular repair (42, 43) . Notably, Xirp1 expression was increased with pressure overload in either mouse strain. The expression of some genes, such as vimentin, was upregulated similarly in MIF KO and WT hearts in response to pressure overload, whereas others were differentially regulated. These are shown in Table 2 . Of particular note was the 4-fold difference in the expression of the ROS-generating mitochondrial oxidase NOX4 in response to pressure overload, which was increased 3-fold in WT hearts and 10-fold in MIF KO hearts (Fig. 2B) . Immunoblot analysis of NOX4 protein confirmed the fourfold difference in expression between MIF KO and WT TAC hearts ( Fig. 2A) . However, NOX4 protein but not mRNA was significantly higher even at baseline (sham) in MIF KO hearts compared with WT hearts. In contrast, the significant increase in NOX4 mRNA was not observed in NOX4 protein in WT hearts in response to TAC (Fig. 2A) .
To further assess the regulatory role of MIF in maintaining redox homeostasis, we measured the protein content of mitochondrial SOD2 and UCP3 and the enzymatic activities of SOD2, GPX, and aconitase, a mitochondrial enzyme sensitive to oxidative damage. SOD2 protein was significantly decreased in MIF KO hearts of both sham and 10-day TAC animals (Fig.  2C) , with mitochondrial SOD activity significantly lower in hypertrophied MIF KO hearts (Fig. 2E) . In contrast, SOD activity in the cytosolic fraction of LVs did not differ among the four groups of animals (data not shown). UCP3, a mitochondrial protein shown to mitigate ROS production (34) , was significantly reduced in MIF KO hearts both at baseline (sham) and after 10-day TAC and was also lower in WT TAC hearts compared with WT sham hearts (Fig. 2D ).
Altered expression of mitochondrial UCP3, SOD2, glutathione-S-transferase (GST)-1, and NOX4 in hearts of MIF KO hearts would be expected to increase oxidative stress. Thus, as an indicator of oxidative stress, we measured mitochondrial aconitase activity because its iron-sulfur cluster is inactivated by superoxide, as we and others (6, 22) have previously shown in the postischemic heart. Aconitase activity was significantly lower in hypertrophied MIF KO hearts compared with WT hearts (Fig.  2F) . Although aconitase activity was measurable in cytosolic fractions, there were no differences in activity among the groups; similarly, total cytosolic GPX activity was not different among the experimental groups (48.6 Ϯ 4.6, 44.7 Ϯ 2.5, 46.8 Ϯ 7.5, and 53.7 Ϯ 7.1 nmol·min proteins (13, 17, 50) . A previously published study (45) has shown that extracellular recombinant MIF provides protection of the postischemic myocardium by inhibiting activation of the JNK pathway through a cell surface CD74 receptor-mediated mechanism. Despite the increased expression of CD-74 and increased circulating MIF in WT mice after TAC (Fig. 1, C and D) , we found no increase in JNK phosphorylation in the heart (Fig. 3) , nor was there activation of JNK in MIF KO hearts in response to hypertrophy. Other studies have shown that MIF mediates its biological activities through receptor-activated MAPK signaling pathways (for a review, see Ref. 8); however, we found no consistent changes in ERK1/2 phosphorylation in response to hypertrophy in MIF KO or WT hearts (Fig. 3) . Another signaling pathway known to promote cardiac myocyte survival and growth is PKB/Akt (55). Phosphorylation of Akt (at Ser 473 or Thr 308 ) was not significantly different in any experimental group (Fig. 3) .
MIF has been reported to activate mitogenic responses in proliferative cells by inhibiting p53 tumor suppressor activity (40) , and by interacting directly with Jab1/CSN5 (20), a component of the COP9 signalosome that regulates E3 ubiquitin ligase activity, MIF may regulate the degradation and stability of p53, c-Jun, and p27
Kip1 (18) . We examined cell cycle inhibitors (p21 CIP1 and p27 Kip1 ) and regulators of cell growth (GSK-3␣ and GSK-3␤) (33, 58) . Phosphorylation of cytosolic p21 CIP1 was increased in response to hypertrophy, with a significantly greater increase (ϳ40%) of p-p21 CIP1 in MIF KO hearts compared with WT TAC hearts (Fig. 4A) . Since the increase in p-p21 paralleled the increase in total p21 protein, the protein was largely phosphorylated. In contrast, p21 protein in the nuclear fraction was not phosphorylated, but it was increased in response to hypertrophy in both WT and MIF KO hearts, with significantly more p21 in MIF KO hearts (Fig. 4B) . Cdk2, which has been associated with cardiac hypertrophy (25) and is a downstream target of p21, was upregulated to a similar extent in WT and MIF KO hypertrophied hearts (Fig. 4C) . In contrast, p27
Kip1 protein remained unaltered by MIF deficiency or hypertrophy (Fig. 4C ). There were also no significant changes in the cellular content of Jab1/CSN5 or p53 under these experimental conditions (Fig. 4, C and D) . coarctation; MIF, macrophage migration inhibitory factor; KO, knockout; Als2, amyotrophic lateral sclerosis 2; Xirp1, xin actin-binding repeat containing 1; Ercc2, excision repair; Fancc, Fanconi anemia; Gab1, growth factor receptor-bound protein 2-associated protein 1; Gpx, glutathione peroxidase; Gstk1, glutatione-S-transferase-1; Nox4, NADPH oxidase 4; Nudt15, nucleoside diphosphate-linked moiety X; Park7, Parkinson disease 7; Prdx5, peroxiredoxin 5; Prdx6-rs1, peroxiredoxin 6-related sequence 1; Serpinb1b, serine (cys) peptidase inhibitor; Slc41a3, solute carrier family 41, member 3; SOD2, mitochondrial superoxide dismutase; Txnip, thioredoxin-interacting protein; Txnrd, thioredoxin reductase; Ucp3, uncoupling protein 3 (a mitochondrial proton carrier); Vim, vimentin. *Only P values of genes that were expressed significantly differently from the WT sham group are shown. GSK-3 has been shown to be inactivated in the hypertrophic myocardium when phosphorylated by upstream kinases such as Akt. However, the function of the two GSK-3 isoforms differs, with GSK-3␤ phosphorylation in response to pressure overload leading to fibrosis, increased hypertrophy, and LV dysfunction, whereas phosphorylation of GSK-3␣ appears to act in a compensatory fashion (33) . To address the role of GSK-3 isoforms in the hypertrophic growth of MIF KO hearts, we measured the phosphorylation of cytosolic and nuclear GSK-3 isoforms. The most remarkable changes were observed in the GSK-3␣ isoform, with significant increases in p-GSK-3␣ in the cytosolic fraction of MIF KO hearts (Fig. 5A) . Phosphorylation of nuclear GSK-3␣ was also increased, albeit not significantly, with a decrease in total GSK-3␣ protein content in MIF KO hearts (Fig. 5B) . Although p-GSK-␣ expression was significantly different between WT and MIF KO hearts, the difference between WT and MIF KO hypertrophied hearts did not reach statistical significance. We also observed a trend toward increased phosphorylation of GSK-3␤ in both cytosolic and nuclear fractions of MIF KO hearts and in the cytosol of WT TAC hearts (Fig. 5, C and D) .
Overexpression of WT MIF but not MIF redox mutant rescues cardiomyocytes after oxidative/reductive stress. An essential function of this pleiotropic factor is its oxidoreductase activity, which we and others (22, 29, 41) have shown to be important in maintaining cellular redox homeostasis in the heart and other tissues. To study the importance of MIF oxidoreductase activity in response to cellular stress, we transduced primary NRVMs with an adenovirus expressing a mutant MIF protein lacking redox activity (Ad-C60S). To elicit an oxidative/reductive stress response, cells were exposed to a reduced oxygen environment (hypoxia) or hypoxia followed by reoxygenation. The effects of WT or mutant MIF overexpression on cell death and the GSH-to-GSSG ratio were measured. The effects of Ad-MIF expression on measures of apoptosis under control conditions were not different from Ad-LacZ (and thus are not shown). As shown in Fig. 6A , ϳ2.5-fold overexpression of WT MIF (Ad-MIF) significantly reduced cleaved caspase 3 in cells exposed to hypoxia, whereas caspase 3 activation was increased by Ͼ2-fold when redox mutant MIF protein was overexpressed (Ad-C60S). Apoptosis was directly measured by quantifying cytosolic oligonucleosomes, and the results supported a protective effect of WT MIF overexpression on cardiomyocytes exposed to hypoxic stress (Fig. 6B) . Intracellular oxidative stress, as measured by GSH-to-GSSG ratios, showed that MIF overexpression significantly improved the intracellular redox environment in cells exposed to hypoxia (Fig. 6C) . This protective antioxidative effect of MIF on cell survival could be mimicked by treatment of cardiomyocytes with a reducing agent, 2-MPG, during exposure to hypoxia and reoxygenation (Fig. 6D) . These data further support a potentially important oxidoreductive role of MIF in the heart during stress conditions, including hypertrophic stress, which is known to promote ROS production.
DISCUSSION
The seminal results in the present study support our primary hypothesis that MIF functions to decrease oxidative/reductive stress and thus attenuates myocardial hypertrophy in response to hemodynamic load. Using an MIF gene deletion mouse model, we have shown that deficiency of MIF resulted in significantly greater cardiac hypertrophy with increased fibrosis in response to pressure overload compared with WT hearts. In WT mice, MIF protein was detected in the circulation of 10-and 28-day TAC animals, with increases in myocardial expression of the MIF receptor, CD74, in both WT and MIF KO hearts. Several recent studies (36, 45) have supported a cardioprotective effect of MIF on the postischemic myocardium, which signals through the CD74 receptor, resulting in AMP kinase activation and suppression of the JNK pathway. However, in the present study, neither AMP kinase nor JNK phosphorylation was significantly altered in response to hemo- Kip1 , and Jun activation domain-binding protein-1 (Jab1)/CSN5 (C) and p53 (D) expression in WT and MIF KO hearts subjected to 10-day TAC and sham operation. dynamic stress in either WT or MIF KO hearts. An MIF homolog, D-dopachrome tautomerase (D-DT), which binds CD74 cell surface receptor with high affinity and initiates proinflammatory responses but lacks oxidoreductase activity, has been recently reported (35) . Thus, D-DT cannot compensate for the loss of MIF redox activity in MIF KO mice and is unlikely to account for the augmented hypertrophic response observed in MIF KO TAC hearts since our data showed that expression of CD74 was induced to a similar extent in both WT and MIF KO hearts in response to pressure overload. It follows, therefore, that the intracellular oxidoreductase activity of MIF likely plays a key role in attenuating stress in response to hypertrophic stimuli. However, we cannot rule out a role for the increased circulating MIF that may activate receptor-initiated intracellular signaling mechanisms that participate in the myocardial response to pressure overload.
MIF has been shown to be a regulator of innate immunity that promotes proinflammatory functions of immune cells (8) .
Since circulating MIF was elevated in TAC animals and expression of its cell surface receptor, CD74, was increased in the heart, it was reasonable to ask whether its proinflammatory function played a role in the hypertrophic response. However, we failed to observe any differences in activation of known MIF receptor-mediated intracellular signaling pathways between WT and MIF KO mice. Furthermore, systemic inflammation was not evident in this hemodynamic stress model, although we cannot rule out this possibility at a time point earlier than 10 days after coarctation.
To determine how MIF deficiency altered the oxidative stress response of the myocardium to pressure overload, we studied the expression of 84 stress-specific genes. Of the 20 genes whose expression was altered in hypertrophied hearts, 11 genes were differentially regulated in MIF KO compared with WT hearts, producing a phenotype indicative of oxidative stress. Particularly striking was the 10-fold increase in NOX4 mRNA in MIF KO TAC hearts compared with the 3-fold increase in WT TAC hearts, which was similar to that previously reported in WT mice (1, 7) . Protein analysis showed similar increases in NOX4 in MIF KO hypertrophied hearts, but, in contrast to the mRNA data, NOX4 protein was significantly higher even at baseline before TAC. Ago et al. (1) have recently shown that NOX4 is expressed primarily in the mitochondria and that mitochondrial proteins containing iron-sulfur clusters, such as adenine nucleotide translocator-1, citrate synthase, and aconitase, could be oxidized by O 2 Ϫ /H 2 O 2 generated by NOX4. These authors also reported that cysteine residues of many mitochondrial proteins were oxidized to a greater extent in transgenic NOX4 mice than in WT mice. In support of an increased oxidative environment as a result of NOX4 expression in the hypertrophied myocardium, we found that mitochondrial aconitase activity was significantly reduced in MIF KO but not WT TAC hearts. Further evidence supporting an essential role of NOX4 in O 2 Ϫ production in mitochondria derives from a study (23) in which increased O 2 Ϫ production induced by pressure overload was abolished in cardiac-specific NOX4 KO mice. To maintain intracellular redox homeostasis, mitochondrial MnSOD converts reactive O 2 Ϫ to H 2 O 2 , which serves as a mechanism to protect mitochondrial proteins from oxidation (30) . We found that mitochondrial SOD activity was significantly reduced in MIF KO hearts but not WT hearts when subjected to pressure overload, further supporting a role for MIF in redox homeostasis.
There were concurrent decreases in other antioxidant defense proteins in MIF KO hypertrophied hearts, including mitochondrial UCP3, GST-1, and cytosolic peroxiredoxin-5. Mitochondrial UCP3 has been shown to reduce excessive production of ROS (31) and to prevent lipid peroxidation and reduce damage to mitochondrial proteins (3, 5) . UCP3 has also been reported to be upregulated in hearts exposed to ischemic preconditioning, resulting in attenuated infarct size and improved functional outcomes (34) . GSTs encompass a family of enzymes that conjugate glutathione to various endogenous molecules; the -class GSTs with peroxidase activity are localized to mitochondria and peroxisomes and probably function to detoxify lipid peroxides generated during oxidative stress (38) . Taken together, the reduced expression of antioxidant proteins, UCP3 and GST-1, in the MIF KO heart subjected to TAC would further stress the myocardium, in which ROS generated by increased mitochondrial NOX4 would promote protein and lipid oxidation and myocyte dysfunction. When we examined the fold changes in the expression of redox-related genes, the magnitude of change was greater in MIF KO TAC hearts than in WT TAC hearts, with 18 versus 8 genes differentially regulated, respectively. Expression of only 2 of 84 genes was significantly different at baseline (sham) between WT and MIF KO mice. Thus, the marked hypertrophy of the MIF KO heart in response to pressure overload is, in large part, a result of increased oxidative stress due to the loss of MIF redox function and to altered expression of antioxidants and ROS-generating enzymes. The importance of MIF's oxidoreductase activity on cell survival was examined by overexpressing redox dead MIF mutant in cultured neonatal rat cardiomyocytes. Exposure of these myocytes to hypoxic conditions increased cell death, whereas overexpression of WT MIF improved survival and normalized the GSH-to-GSSG ratio, a measure of oxidative stress. The magnitude of effect of WT MIF overexpression on cell survival was similar to treatment with an antioxidant molecule, 2-MPG. We choose hypoxia/reoxygenation conditions to simulate redox stress in this cell culture model since a hypertrophic model that generated redox stress in cell culture was difficult to show.
MIF has been reported to interact directly with Jab1/CSN5 (20, 40) , and thus it can potentially regulate the activity of SCF ubiquitin ligases and the degradation of specific proteins, including p53 and p27
Kip1 (18, 44, 52) . However, we did not observe changes in either p53 or p27 protein expression in the cytosol or nucleus in response to hypertrophy or to deficiency of MIF. In contrast, Cdk inhibitor p21 CIP1/WAF1 was increased in the hypertrophied myocardium and was significantly greater in MIF KO hearts compared with WT TAC hearts. Phosphorylation of p21 has been shown to promote its retention in the cytosol, and, likewise, we found only p-p21 in the cytosol and no p-p21 in the nucleus. Both PKB/Akt and GSK-3 have been reported to phosphorylate p21 (16, 56) , which increases its stability and inhibits its binding to proliferating cell nuclear antigen, which plays a role in adult myocyte hypertrophy (13) . MIF receptor-initiated activation of PKB/Akt has been described in proliferative cells (28) ; however, this signaling pathway is unlikely to explain the robust hypertrophic response in MIF KO hearts in the present study, even though CD74 expression was upregulated. Akt activation is only one of several signaling pathways leading to the phosphorylation and inhibition of GSK-3 activity, which removes its negative constraint on cardiac hypertrophy (9, 48) . Thus, in basal unstimulated conditions, GSK-3s are active serine/threonine kinases that function to limit cardiac growth by phosphorylating positive mediators of hypertrophy. The two isoforms, GSK-3␣ and GSK-3␤, have distinct functions, with GSK-3␣ functioning to protect against TAC-induced hypertrophy, as shown by a study (58) using GSK-3␣ KO mice. Similar to the effects of deletion of GSK-3␣, we observed a significant increase in the phosphorylation of cytosolic GSK-3␣ in MIF KO hearts after 10-day TAC. However, we could not show a significant difference in cytosolic p-GSK-3␣ between WT and MIF KO TAC hearts that could account for the differences in the hypertrophic response to pressure overload. The effect of increased p-GSK-3␣ at baseline in the MIF KO heart is presently unclear, but indicates that additional mechanisms mediating hypertrophic response to stress may be playing a role in the MIF KO heart. There remains some controversy regarding the role of GSK-3␣ in cardiac hypertrophy, as evidenced by results from a constitutively active GSK-3␣ S21A knockin mouse model in which pressure overload promoted hypertrophy, fibrosis, and myocyte apoptosis with a preferential localization of GSK-3␣ in the nucleus (33) . We observed a significant decrease of total nonphosphorylated GSK-3␣ in the nucleus, with no significant change in its phosphorylation status. Many of the observed changes in GSK-3 show a trend toward differential expression in the MIF KO heart; thus, their significance in the hypertrophic response may be meaningful only when considered in context with other molecular changes.
In conclusion, the present data support an important role for the intrinsic oxidoreductase activity of MIF to maintain redox homeostasis within the cell, such that loss of this activity in the heart results in augmented cardiac hypertrophy in response to hemodynamic stress. Furthermore, increased circulating MIF in the hemodynamically stressed animal may provide benefits through currently unknown mechanisms. The increase in ROSgenerating enzymes, such as NOX4, and the reduction of antioxidant mitochondrial proteins, such as UCP3 and GST-1, in the MIF-deficient heart may be secondary mechanisms by which the MIF-deficient heart fails to cope with cellular stress. Thus, targeting MIF's redox activity, similar to that of other intrinsic antioxidants, such as thioredoxin, may provide benefits for patients with cardiomyopathy, pathological hypertrophy or heart failure.
